MyProstateScore 2.0 is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 gene transcripts, including T2:ERG, the most specific prostate cancer biomarker available. The algorithm optimizes accuracy and provides stratified insight.
